UConn Today – A pair of Ph.D. students at the University of Connecticut are developing a new technology to improve the efficiency of cancer treatment. They hope their innovation could someday significantly reduce mortality rates in cancer patients.
CCEI
Why it pays to have Gen Z women on business teams
Fox Business – For most CEOs, HR partners and operations directors who have never given much thought to Gen Z, those born between 1995-2010, data from a new report should be their wake-up call: Pay attention to the “innovation Opens a New Window. generation” if you want to drive growth and global competitiveness.
Torigen Pharmaceuticals Secures $3.1 Million in Series A Financing
Financial Content – Torigen Pharmaceuticals, a company developing personalized cancer immunotherapies for the veterinary market, announced today the completion of a $3.1 million Series A financing round led by Connecticut Innovations, which included the conversion of outstanding convertible debt and interest.
UConn-based startup, DeMay Bio, is Dealy’s second act in entrepreneurship
Hartford Business Journal – Caroline Dealy never expected to be an entrepreneur. In fact, as an associate professor of reconstructive sciences, orthopedic surgery and cell biology at UConn Health, Dealy knew very little about the business of bioscience.